HBP1 and nasopharyngeal carcinoma: These data demonstrate that HBP1 knockdown via miR-29c agomir intratumoral injections inhibited xenograft growth in vivo, which was in accordance with the results that HBP1 expression inhibition decreased NPC cells growth and proliferation in vitro.